Personal exposure to HBCDs and its degradation products via ingestion of indoor dust

Personal exposures via ingestion of indoor dust to α-, β-, and γ-hexabromocyclododecanes (HBCDs) and the degradation products (pentabromocyclododecenes (PBCDs) and tetrabromocyclododecadienes (TBCDs)) were estimated for 21 UK adults. Under an average dust ingestion scenario, personal exposures ranged from 4.5 to 1851 ng ΣHBCDs day− 1; while the range under a high dust ingestion scenario was 11 to 4630 ng ΣHBCDs day− 1. On average, personal exposure to ΣHBCDs via dust ingestion in this study was 35% α-, 11% β-, and 54% γ-HBCD. However, while exposure to β-HBCD (4–18% of ΣHBCDs) was relatively consistent with the proportion of this diastereomer in the HBCD commercial formulation; exposures to α- and γ-isomers (11–58% and 29–82% of ΣHBCDs respectively) showed substantial variation from the commercial formulation pattern. Personal exposures to ΣTBCDs (median = 0.2 ng day− 1 under an average dust ingestion scenario) and ΣPBCDs (1.4 ng day− 1) were significantly lower (p < 0.05) than for ΣHBCDs (48 ng day− 1). Despite this, the exposure of one participant to ΣPBCDs exceeded the exposure to ΣHBCDs received by 85% of the other participants. On average, house dust provided the major contribution to personal exposure via dust ingestion to all target compounds due to the large time fraction spent in houses. In contrast, although participants spent less time in cars than in offices, car dust makes a higher average contribution (17%) to ΣHBCDs exposure than office dust (13%).